The NDCRC is conducting an evaluation of the implementation, breadth, and use of prescription drug monitoring programs (PDMP) at the state level. These data will be analyzed in conjunction with opioid prescribing rates, comparing rates alongside data from states that do and no not have PDMPs. We hypothesize that the implementation of PDMPs will correlate with a decrease in opioid prescribing rates.
As of June 30, 2022, NDCRC staff are evaluating data collected and the gaps therein to see if the information can be presented in a meaningful way with viable conclusions drawn. This study is expected to continue into fall 2022.
As of December 31, 2022, NDCRC staff have drafted two separate publications detailing the characteristics of PDMPs and their unintended consequences. These documents are under internal review by NDCRC directors before being sent to BJA.
Please check the box next to the following questions if the answer is 'yes'.
Please enter the applicable Event Date if there is an Event associated with this TTA.
When entering an Event Date, the Time is also required.
If the TTA is targeted to a particular audience or location, please complete the questions below.
Milestones are an element, activity, work product, or key task associated with completing the TTA (e.g. kick-off meeting, collect data from stake holders, deliver initial data analysis).
Please complete the fields below, if applicable, to create a milestone for this TTA.
Please respond to the Performance Metrics below. The Performance Metrics questions are based on the TTA Type indicated in the General Information section of the TTA.
Please submit a signed letter of support from your agency’s executive or other senior staff member. The letter can be emailed to or uploaded with this request. The letter should be submitted on official letterhead and include the following information:
- General information regarding the request for TTA services, i.e., the who, what, where, when, and why.
- The organizational and/or community needs specific to the request for TTA services.
- The benefits or anticipated outcomes from the receipt of TTA services.
By submitting this application to BJA NTTAC, I understand that upon approval of this application for TTA, the requestor agrees to keep BJA NTTAC informed of any circumstances that may impact the delivery of the TTA, including changes in the date of the event, event cancellation, or difficulties communicating with the assigned TTA provider.
Please call [site:phone] if you need further assistance completing this application.